Clinical Trials Browser

Interventional × Hepatic Insufficiency × Clear all

NCT07559474 2026-04-30

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Phase 1 Not yet recruiting

Liver Diseases, Lymphoma, Follicular, Hepatic Insufficiency

NCT07550634 2026-04-24

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

Phase 1 Not yet recruiting

Lymphoma, Follicular, Hepatic Insufficiency

NCT01022476 2026-04-06

LIVERAL

Phase 1/2 Completed

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

NCT05209295 2026-01-12

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Phase 1 Terminated

Neoplasms, Hepatic Insufficiency

NCT07185360 2025-09-22

LIVER-TRACK

Phase NA Not yet recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Hepatic Insufficiency

NCT03172884 2021-04-28

Study of Copanlisib in Hepatic or Renal Impairment

Phase 1 Completed

30 enrolled 20 charts

Hepatic Insufficiency, Renal Insufficiency

NCT01860326 2016-04-28

Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects

Phase 1 Completed

Lymphoma, Follicular, Hepatic Insufficiency

NCT01273493 2016-02-15

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Phase 1 Completed

Liver Diseases, Neoplasm Metastasis, Hepatic Insufficiency